Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2350

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy ; volume:11 ; number:1 ; day:30 ; month:4 ; year:2010 ; pages:1-10 ; date:12.2010
BMC medical genetics ; 11, Heft 1 (30.4.2010), 1-10, 12.2010

Creator: Rodríguez-García, María Isabel

Contributor: Monserrat, Lorenzo
Ortiz, Martín
Fernández, Xusto
Cazón, Laura
Núñez, Lucía
Barriales-Villa, Roberto
Maneiro, Emilia
Veira, Elena
Castro-Beiras, Alfonso
Hermida-Prieto, Manuel
SpringerLink (Online service)

DOI: 10.1186/1471-2350-11-67

URN: urn:nbn:de:1111-2016071511454

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rodríguez-García, María Isabel
Monserrat, Lorenzo
Ortiz, Martín
Fernández, Xusto
Cazón, Laura
Núñez, Lucía
Barriales-Villa, Roberto
Maneiro, Emilia
Veira, Elena
Castro-Beiras, Alfonso
Hermida-Prieto, Manuel
SpringerLink (Online service)

Other Objects (12)

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy with a Twist

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C

Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy

Related objects

Reset password